Assessing simulation run time requirements to achieve stabilized absolute and incremental cost effectiveness results in type 2 diabetes- a study using the ims core diabetes model
May 1, 2014, 00:00
10.1016/j.jval.2014.03.1468
https://www.valueinhealthjournal.com/article/S1098-3015(14)01519-8/fulltext
Title :
Assessing simulation run time requirements to achieve stabilized absolute and incremental cost effectiveness results in type 2 diabetes- a study using the ims core diabetes model
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)01519-8&doi=10.1016/j.jval.2014.03.1468
First page :
A252
Section Title :
Diabetes/Endocrine Disorders I
Open access? :
No
Section Order :
951